[ Herbal Remedies ]

Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1


Dapagliflozin (Farxiga, AstraZeneca) is a selective SGLT2 inhibitor approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. The possibility that T2D patients might be at increased risk in developing AD has serious societal implications. This is a selective and reversible inhibitor cotransporter 2 sodium-glucose (SGLT2) acting independently of insulin, aiding removal of excess glucose in the body, differently from as what do the rest of antidiabetic drugs. Dapagliflozin is, after the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin (TRAJENTA; a-t 2011; 42: 73-4) and the insulin analogue degludec (TRESIBA), the third diabetes drug to either be withdrawn from the market or not even to be launched in the first place, due to their benefit assessment within the framework of the AMNOG (Pharmaceutical Market Restructuring Act). At this time, no PAAT is available for Forxiga. Dapagliflozin, administered from initiation of high-fat feeding, reduced the development of hyperglycaemia; after 24 days, blood glucose was 8.6 ± 0.5 vs. Back in May, the Committee for Medicinal Products for Human Use of the European Medicines Agency published a positive opinion on Forxiga.

Most patients were on multiple medications, including antidiabetic medications and insulin, with 41% to 44% in both studies being treated with insulin or oral agents and about 40% being treated with at least two oral therapies in both studies, Cefalu said. With

Tags: , ,
[ Diabetes Type 1 ]

Fourth Annual Diabetes Blog Week!

“This is what you should tell people!” she said slamming her hand down on the table. The problem is compounded by an increase in onset of Type 2 Diabetes at an early age predisposing them to diabetes-related complications at a very young age (1). Would you try to see the positives? In the Perspective article Population Approaches to Prevention of Type 2 Diabetes, Martin White (University of Cambridge, United Kingdom) notes that while lifestyle interventions aimed at increasing healthy behaviors like exercise and appropriate diet among high-risk individuals have been successful and cost-effective in randomized controlled trials, scale-up of these programs will likely lead to drop-offs in effectiveness and could leave the most vulnerable populations behind. Past studies have suggested that diabetes raises the risk for Alzheimer’s disease although it’s not entirely clear why. After lunch, the children with diabetes went to a seminar with Jan Anderson, a marathon swimmer. Results from a recent survey by the American Diabetes Association show that the diabetes camp experience has a positive and lasting effect on how young people view themselves and their diabetes.

In both type 1 and type 2 diabetes, scientists have determined that many genes are involved in setting the stage for the possibility that diabetes can develop. It was under eight but it wasn’t under seven, the magic number I had read about. I had been to school with a couple of people with diabetes

Tags: , ,